A true inspiration to all learners.
Greg Gimenez is a Senior Research Fellow in the Department of Pathology and Molecular Medicine within the Faculty of Medicine at the University of Otago in Dunedin. His qualifications include BTS (Cannes) and ESIL Biotech (Aix-Marseille II). His research interests encompass genomics and bioinformatics, with a focus on Next Generation Sequencing (NGS) and their translational applications towards a better understanding of immunological and pathologic issues.
Gimenez's publication record includes several peer-reviewed articles. These comprise "PAX gene expression in autosomal dominant polycystic kidney disease contributes to cyst expansion and regulates a gene network associated with cyst growth" (Zheng, Q., Stayner, C., Reid, G., Gimenez, G., & Eccles, M. R., Human Molecular Genetics, 2026), "A functional role for septin-2 in the maintenance of the axon initial segment and in human cognitive development" (Weiss, L., et al., including Gimenez, G., Gumy, L. F., & Robertson, S. P., Brain, 2025), "Pre-treatment DNA methylome and transcriptome profiles correlate with melanoma response to anti-PD1 immunotherapy" (Hossain, S. M., Gimenez, G., et al., Cancer Letters, 618, 217638, 2025), "Liquid biopsy based DNA methylation biomarker panel for facilitating minimally invasive prostate cancer detection" (Dutta, A., Yee, A., Ghosh, A., Zarrabi, A., Gimenez, G., Smith, J., Rodger, E., & Chatterjee, A., Proceedings of the Genetics Otago (GO) Annual Symposium, 2025), and "Cohesin rad21 mutation dysregulates erythropoiesis and granulopoiesis output within the whole kidney marrow of adult zebrafish" (Gimenez, G., Kalev-Zylinska, M. L., Morison, I., Bohlander, S. K., Horsfield, J. A., & Antony, J., American Journal of Physiology: Cell Physiology, 328, C9-C19, 2025).
